ANIXA BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ANIXA BIOSCIENCES, INC. (ANIX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$2.32 million for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-01-12
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$2.32M.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$2.67M.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$2.08M.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$2.89M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-10-31 | -$2.32M 10-K · filed 2026-01-12 | |
| 2024-10-31 | -$2.67M 10-K · filed 2026-01-12 | |
| 2023-10-31 | -$2.08M 10-K · filed 2025-01-10 | |
| 2022-10-31 | -$2.89M 10-K · filed 2024-01-16 | |
| 2021-10-31 | -$2.76M 10-K · filed 2023-01-04 | |
| 2020-10-31 | -$2.12M 10-K · filed 2022-01-04 | |
| 2019-10-31 | -$2.48M 10-K · filed 2021-01-07 | |
| 2018-10-31 | -$3.28M 10-K · filed 2020-01-09 | |
| 2017-10-31 | -$1.70M 10-K · filed 2019-01-11 | |
| 2016-10-31 | -$1.71M 10-K · filed 2018-01-09 | |
| 2015-10-31 | -$469.00K 10-K · filed 2016-12-08 | |
| 2014-10-31 | -$3.27M 10-K · filed 2015-12-23 | -$326.60K 10-K · filed 2015-01-29 |
| 2013-10-31 | -$3.43M 10-K · filed 2015-01-29 | |
| 2012-10-31 | -$1.45M 10-K/A · filed 2014-01-17 | |
| 2011-10-31 | -$2.31M 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |